Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer

Despite improvements in surgery and medical treatments, epithelial ovarian cancer (EOC) remains the most lethal gynaecological malignancy. Aim of this study is to investigate the preclinical immunotherapy activity of cytokine-induced killer lymphocytes (CIK) against epithelial ovarian cancers, focus...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Capellero, S., Erriquez, J., Melano, C., Mesiano, G., Genta, S., Pisacane, A., Mittica, G., Ghisoni, E., Olivero, M., Di Renzo, M. F., Aglietta, M., Sangiolo, D., Valabrega, G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160190/
https://ncbi.nlm.nih.gov/pubmed/32296104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-63634-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller